Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 10:43 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 25–48 of 319 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Respiratory Illness Clear all

Conditions: Common Cold
Interventions: 3804-250A, 3804-291; Drug
Lead sponsor: The Dial Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 411 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008
U.S. locations: 2
States / cities: Paramus, New Jersey • Charlottesville, Virginia

Conditions: Altitude Edema
Interventions: Advair HFA, Placebo; Drug
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 50 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Depression
Interventions: Escitalopram, Placebo; Drug
Lead sponsor: University of Minnesota; Other
Eligibility: 25 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Pregnancy, IUGR, Preeclampsia
Interventions: Collection of myometrial, cord blood, and placental tissue samples; Procedure
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 84 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2026
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Critical Illness, Sepsis, Respiratory Insufficiency
Interventions: Glutamine; Drug
Lead sponsor: Christiana Care Health Services; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2007
U.S. locations: 1
States / cities: Newark, Delaware

Conditions: Tracheostomy Complication, Critical Illness, Nutritional Deficiency
Interventions: Feeds continued, Feeds held; Other
Lead sponsor: State University of New York at Buffalo; Other
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 6
States / cities: Danbury, Connecticut • West Palm Beach, Florida • Kansas City, Missouri + 3 more

Conditions: Severe Acute Respiratory Syndrome, COVID
Interventions: SARS-CoV-2 plasma; Drug
Lead sponsor: Henry Ford Health System; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 3
States / cities: Novi, Michigan • Southfield, Michigan • Warren, Michigan

Conditions: Venous Thrombosis, Pulmonary Embolism
Interventions: Apixaban, Enoxaparin; Drug
Lead sponsor: Bristol-Myers Squibb; Industry
Eligibility: 40 Years and older
Enrollment: 6,758 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2011
U.S. locations: 48
States / cities: Birmingham, Alabama • Huntsville, Alabama • Phoenix, Arizona + 42 more

Conditions: Influenza
Interventions: VRC-FLUMOS0116-00-VP( FLUMos-v2); Biological
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years to 50 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Respiratory Tract Infections, Wheezing
Interventions: Not listed
Lead sponsor: Duke University; Other
Eligibility: 3 Months to 24 Months
Enrollment: 5 participants
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Respiratory Disease, Acute Respiratory Infection, Respiratory Infection, Upper Respiratory Infection
Interventions: Online Tutorial, Webinars, Booster Sessions, Feedback Reports, Parent Survey; Other
Lead sponsor: Seattle Children's Hospital; Other
Eligibility: 6 Months to 10 Years
Enrollment: 2,728 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 20
States / cities: Paragould, Arkansas • Eureka, California • Durango, Colorado + 16 more

Conditions: AMS, Acute Mountain Sickness
Interventions: Immediate descent from altitude., Diphenhydramine, Prochlorperazine 10 mg; Other · Drug
Lead sponsor: CHRISTUS Health; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Corpus Christi, Texas

Conditions: Cancer, Cardiac Disease, Pulmonary Disease, Neuro-Degenerative Disease, Renal Disease, Stroke, Sepsis, Hepatic Disease
Interventions: Active Intervention, Usual Care; Other
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 55 Years and older
Enrollment: 209 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 4
States / cities: Alexander City, Alabama • Meridian, Mississippi • Picayune, Mississippi + 1 more

Conditions: Acute Respiratory Failure Requiring Mechanical Ventilation
Interventions: EyeControl Eye-tracking Device; Device
Lead sponsor: Emory University; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Critical Illness, Acute Respiratory Distress Syndrome, Septic Shock
Interventions: Telehealth; Other
Lead sponsor: Vanderbilt University; Other
Eligibility: 18 Years and older
Enrollment: 91 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Chronic Mental Illness, Chronic Physical Illness
Interventions: Patient-Directed Wellness Account, Health Navigator; Behavioral
Lead sponsor: University of Florida; Other
Eligibility: 21 Years to 55 Years
Enrollment: 1,663 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Kidney Failure, Respiratory Failure, Critical Illness, Shock
Interventions: Not listed
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years and older
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: COVID-19, SARS-CoV-2, Coronavirus, Influenza -Like Illness, Lower Resp Tract Infection, Upper Resp Tract Infection
Interventions: Not listed
Lead sponsor: Duke University; Other
Eligibility: Not listed
Enrollment: 9,207 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Critical Illness, Sepsis, Shock, Septic, Shock, Respiratory Failure, Respiratory Distress Syndrome, Adult, Shock, Hypovolemic, Chronic Disease
Interventions: Peer Support with Motivational Interviewing, Usual Care Group; Behavioral
Lead sponsor: University of Texas at Austin; Other
Eligibility: 18 Years to 65 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Temple, Texas

Conditions: Acute Respiratory Infection, Influenza-like Illness, Gastrointestinal Infection
Interventions: Multimodal hygiene intervention; Behavioral
Lead sponsor: Kent State University; Other
Eligibility: 18 Years and older
Enrollment: 195 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018
U.S. locations: 1
States / cities: Schenectady, New York

Conditions: Influenza-like Illness, Influenza
Interventions: Online education; Behavioral
Lead sponsor: Centers for Disease Control and Prevention; Federal
Eligibility: 17 Years and older
Enrollment: 3,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2008
U.S. locations: 1
States / cities: Berkeley, California

Conditions: COVID-19
Interventions: Omicron Subvariant-Based SARS-CoV-2 Recombinant Spike Vaccine Adjuvanted With Matrix-M; Biological
Lead sponsor: Sanofi; Industry
Eligibility: 12 Years and older
Enrollment: 669 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 20
States / cities: Fair Oaks, California • Doral, Florida • Atlanta, Georgia + 16 more

Conditions: Respiratory Viral Illnesses: Influenza A/B, RSV, Adenovirus
Interventions: Not listed
Lead sponsor: GenMark Diagnostics; Industry
Eligibility: Not listed
Enrollment: 1,487 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Hershey, Pennsylvania

Conditions: Influenza Like Illness, Asthma, Group A Streptococcal Infection, Pertussis
Interventions: What's Going Around tool, Control; Other
Lead sponsor: Endeavor Health; Other
Eligibility: Not listed
Enrollment: 206,703 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Evanston, Illinois

Search by objective public record fields.

Efficacy Trial of 3804-250A in the Prevention of Cold Illnesses

Advair HFA in Healthy and HAPE Predisposed Subjects

Preventing Depression in People Receiving Mechanical Ventilation in an Intensive Care Unit

Effects of High Altitude on AMPK Activation

Enteral Glutamine in Critical Illness

PUSH-IT Continuing Enteral Feeds for Tracheostomy

Intermediate IND Severe Illness COVID-19 CP

Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness

Trial to Evaluate the Safety, Tolerability, and Immunogenicity of a Mosaic Hexavalent Influenza Vaccine VRC-FLUMOS0116-00-VP (FluMos-v2) in Healthy Adults

A 24 Month Observational Study of Infants 3-24 Months, Who Suffer an Acute Episode of Respiratory Infection and Wheezing Illness

Dialogue Around Respiratory Illness Treatment

Efficacy of Prophylactic Treatment of Oral Prochlorperazine for Acute Mountain Sickness

A Culturally-Based Palliative Care Tele-consult Program for Rural Southern Elders

Eye-Control Trial: Wearable Eye-Tracking Device as Means of Communication

TelePORT Pilot Study

Evaluation of the Texas Wellness Incentives and Navigation (WIN) Project

Observational Study of Blood Pressure Measurements and Continuous Dialysis

COVID-19 Pandemic Response Network

Peer Support for Post Intensive Care Syndrome Self-Management

Kent State University / Price Chopper Employee Wellness Study

REDucing Influenza Among University Students, University of California at Berkeley

Study of a Recombinant Spike COVID-19 Vaccine With Matrix-M in Older Adults and People at Increased Risk of Severe COVID-19

Residual Sample Collection for Respiratory Viral Panel

How Does the Clinical Tool 'What's Going Around' Affect Clinical Practice